Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
01/04/2019 4:11 pm
Bloodwork question about tesamorelin. Baseline, eight months in, and the numbers moved in a direction I did not expect.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
What the growth hormone secretagogue class does pharmacologically does not require the subjective effect to be large to be real.
Timing around sleep matters more than absolute dose with this class.
Happy to be corrected on any of the above.
01/04/2019 5:43 pm
Baseline first.